Provided by Tiger Fintech (Singapore) Pte. Ltd.

Immunovant, Inc.

15.08
-0.1600-1.05%
Volume:60.89K
Turnover:923.72K
Market Cap:2.63B
PE:-5.32
High:15.36
Open:15.26
Low:15.08
Close:15.24
52wk High:34.47
52wk Low:12.72
Shares:174.32M
Float Shares:66.98M
Volume Ratio:0.32
T/O Rate:0.09%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.8352
EPS(LYR):-2.7303
ROE:-77.58%
ROA:-47.07%
PB:4.32
PE(LYR):-5.52

Loading ...

Aug 11, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 11, 2025

Major Issues Report

Form 8-K - Current report
Jul 29, 2025

Major Issues Report

Form 8-K - Current report
Jun 25, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 29, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
May 29, 2025

Major Issues Report

Form 8-K - Current report
May 22, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 01, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Apr 21, 2025

Major Issues Report

Form 8-K - Current report
Mar 19, 2025

Major Issues Report

Form 8-K - Current report
Mar 07, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 14, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 11, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 06, 2025

Major Issues Report

Form 8-K - Current report
Feb 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jan 24, 2025

Major Issues Report

Form 8-K - Current report
Jan 14, 2025

Major Issues Report

Form 8-K - Current report